UAE Longevity & Wellness Pharmaceutical Market Size & Outlook

The longevity & wellness pharmaceutical market in the UAE is expected to reach a projected revenue of US$ 723.8 million by 2033. A compound annual growth rate of 5.5% is expected of the UAE longevity & wellness pharmaceutical market from 2026 to 2033.
Revenue, 2025 (US$M)
$474.9
Forecast, 2033 (US$M)
$723.8
CAGR, 2026 - 2033
5.5%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE longevity & wellness pharmaceutical market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

UAE longevity & wellness pharmaceutical market highlights

  • The UAE longevity & wellness pharmaceutical market generated a revenue of USD 474.9 million in 2025 and is expected to reach USD 723.8 million by 2033.
  • The UAE market is expected to grow at a CAGR of 5.5% from 2026 to 2033.
  • In terms of segment, small molecule pharmaceutical drugs was the largest revenue generating type in 2025.
  • Nutraceuticals & Non-Prescription Longevity Compounds is the most lucrative type segment registering the fastest growth during the forecast period.


Longevity & wellness pharmaceutical market data book summary

Market revenue in 2025USD 474.9 million
Market revenue in 2033USD 723.8 million
Growth rate5.5% (CAGR from 2026 to 2033)
Largest segmentSmall molecule pharmaceutical drugs
Fastest growing segmentNutraceuticals & Non-Prescription Longevity Compounds
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecule Pharmaceutical Drugs, Biologics & Advanced Therapeutics, Nutraceuticals & Non-Prescription Longevity Compounds, Hormone Replacement & Endocrine Therapies


Other key industry trends

  • In terms of revenue, UAE accounted for 0.7% of the global longevity & wellness pharmaceutical market in 2025.
  • Country-wise, Canada is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia longevity & wellness pharmaceutical market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 2,332.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Longevity & Wellness Pharmaceutical Market Companies

Name Profile # Employees HQ Website
Eli Lilly and Company View profile - - -
Merck & Co., Inc. View profile - - -
F. Hoffmann-La Roche Ltd. View profile - - -
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

UAE longevity & wellness pharmaceutical market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to longevity & wellness pharmaceutical market will help companies and investors design strategic landscapes.


Small molecule pharmaceutical drugs was the largest segment with a revenue share of 49.13% in 2025. Horizon Databook has segmented the UAE longevity & wellness pharmaceutical market based on small molecule pharmaceutical drugs, biologics & advanced therapeutics, nutraceuticals & non-prescription longevity compounds, hormone replacement & endocrine therapies covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to UAE longevity & wellness pharmaceutical market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE longevity & wellness pharmaceutical market databook

  • Our clientele includes a mix of longevity & wellness pharmaceutical market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE longevity & wellness pharmaceutical market , including forecasts for subscribers. This country databook contains high-level insights into UAE longevity & wellness pharmaceutical market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE longevity & wellness pharmaceutical market size, by type, 2021-2033 (US$M)

UAE Longevity & Wellness Pharmaceutical Market Outlook Share, 2025 & 2033 (US$M)

UAE longevity & wellness pharmaceutical market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online